Education
About Us
Working with TipRanks
Follow Us
Dr. Reddy's Laboratories Ltd. (IN:DRREDDY)
:DRREDDY
RESEARCH TOOLSreports
Total Valuation
Dr. Reddy's Laboratories Ltd. has a market cap or net worth of ₹1.09T. The enterprise value is ₹1.14T.
Market Cap₹1.09T
Enterprise Value₹1.14T
Share Statistics
Dr. Reddy's Laboratories Ltd. has 834,532,040 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding834,532,040
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Dr. Reddy's Laboratories Ltd.’s return on equity (ROE) is 0.17 and return on invested capital (ROIC) is 13.34%.
Return on Equity (ROE)0.17
Return on Assets (ROA)0.11
Return on Invested Capital (ROIC)13.34%
Return on Capital Employed (ROCE)0.20
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover0.66
Inventory Turnover1.90
Valuation Ratios
The current PE Ratio of Dr. Reddy's Laboratories Ltd. is 16.97. Dr. Reddy's Laboratories Ltd.’s PEG ratio is -0.64.
PE Ratio16.97
PS Ratio0.00
PB Ratio3.34
Price to Fair Value2.88
Price to FCF72.65
Price to Operating Cash Flow24.14
PEG Ratio-0.64
Income Statement
In the last 12 months, Dr. Reddy's Laboratories Ltd. had revenue of 325.54B and earned 56.54B in profits. Earnings per share was 67.88.
Revenue325.54B
Gross Profit190.43B
Operating Income71.84B
Pretax Income76.78B
Net Income56.54B
EBITDA91.61B
Earnings Per Share (EPS)67.88
Cash Flow
In the last 12 months, operating cash flow was 46.13B and capital expenditures -30.81B, giving a free cash flow of 15.32B billion.
Operating Cash Flow46.13B
Free Cash Flow15.32B
Free Cash Flow per Share18.35
Dividends & Yields
Dr. Reddy's Laboratories Ltd. pays an annual dividend of ₹8, resulting in a dividend yield of 0.6%
Dividend Per Share₹8
Dividend Yield0.6%
Payout Ratio11.80%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.68
52-Week Price Change2.16%
50-Day Moving Average1.25K
200-Day Moving Average1.25K
Relative Strength Index (RSI)51.31
Average Volume (3m)68.29K
Important Dates
Dr. Reddy's Laboratories Ltd. upcoming earnings date is Jul 23, 2025, Before Open (Confirmed).
Last Earnings DateMay 9, 2025
Next Earnings DateJul 23, 2025
Ex-Dividend DateJul 10, 2025
Financial Position
Dr. Reddy's Laboratories Ltd. as a current ratio of 1.92, with Debt / Equity ratio of 14.03%
Current Ratio1.92
Quick Ratio1.37
Debt to Market Cap0.05
Net Debt to EBITDA0.35
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Dr. Reddy's Laboratories Ltd. has paid 19.54B in taxes.
Income Tax19.54B
Effective Tax Rate0.25
Enterprise Valuation
Dr. Reddy's Laboratories Ltd. EV to EBITDA ratio is 10.82, with an EV/FCF ratio of 52.40.
EV to Sales3.05
EV to EBITDA10.82
EV to Free Cash Flow52.40
EV to Operating Cash Flow21.36
Balance Sheet
Dr. Reddy's Laboratories Ltd. has ₹57.91B in cash and marketable securities with ₹46.77B in debt, giving a net cash position of -₹11.14B billion.
Cash & Marketable Securities₹57.91B
Total Debt₹46.77B
Net Cash-₹11.14B
Net Cash Per Share-₹13.35
Tangible Book Value Per Share₹274.46
Margins
Gross margin is 57.17%, with operating margin of 22.07%, and net profit margin of 17.37%.
Gross Margin57.17%
Operating Margin22.07%
Pretax Margin23.59%
Net Profit Margin17.37%
EBITDA Margin28.14%
EBIT Margin22.90%
Analyst Forecast
The average price target for Dr. Reddy's Laboratories Ltd. is ₹1,291.67, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target₹1,291.67
Price Target Upside12.45% Upside
Analyst ConsensusModerate Buy
Analyst Count3
Revenue Growth Forecast―
EPS Growth Forecast―